Laury, Anna Ray
Blom, Sami
Ropponen, Tuomas
Virtanen, Anni
Carpén, Olli Mikael
Funding for this research was provided by:
University of Helsinki Doctoral Programme in Clinical Research
Suomen Lääketieteen Säätiö
Orion Research Foundation sr
HUS Diagnostic Center
European Union’s Horizon 2020 research and innovation program for DECIDER (grant agreement no 965193, grant agreement no 965193, grant agreement no 965193, grant agreement no 965193, grant agreement no 965193)
European Union’s Horizon 2020 research and innovation programme for HERCULES (grant agreement 667403)
Finnish Cancer Foundation, Sigrid Juselius Foundation and Finska Läkaresälskapet
Article History
Received: 4 June 2021
Accepted: 9 September 2021
First Online: 27 September 2021
Competing interests
: ARL is a paid consultant on unrelated projects for Aiforia Technologies Oy. SB and TR are employees of Aiforia Technologies Oy. OC and AV have no competing interests.